Venetoclax-rituximab treatment of relapsed/refractory CLL during the COVID-19 pandemic: A real-life experience in selected central-southern italian regions / Molica, S.; Sportoletti, P.; Renzo, N. D.; Musto, P.; Pane, F.; Raimondo, F. D.. - In: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. - ISSN 2035-3006. - 13:1(2021). [10.4084/MJHID.2021.042]
Venetoclax-rituximab treatment of relapsed/refractory CLL during the COVID-19 pandemic: A real-life experience in selected central-southern italian regions
Pane F.;
2021
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Venetoclaxrituximab-treatment-of-relapsedrefractory-CLL-during-the-COVID19-pandemic-A-reallife-experience-in-selected-centralsouthern-italian-regionsMediterranean-Journal-of-Hematology-and-Infectious-Diseases.pdf
accesso aperto
Licenza:
Non specificato
Dimensione
272.13 kB
Formato
Adobe PDF
|
272.13 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
